Washington Marijuana Sales Increase 242% in 2015

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Washington Marijuana Sales Increase 242% in 2015

© Thinkstock

Legal sales of marijuana products totaled more than $709 million in the state of Washington last year, a 242% increase over 2014. By 2020 Washington is expected to post legal sales of recreational marijuana products totaling $2.3 billion, tops among the five states where recreational sales are legal and more than half the projected total of $5.5 billion projected for these states.

The state is projected to receive $636 million in the next five years from its recreational use market, according to the fourth edition of the “State of Legal Marijuana Markets” report compiled by New Frontier and ArcView Market Research. The legal market in 2015 in the United States totaled $5.7 billion, up from $4.6 billion in 2014, an increase of 24%.

Founder and CEO of New Frontier, Giadha DeCarcer, said:

In 2014, adult use sales in Washington accounted for 18.6% of all legal adult use sales in the country. By the end of 2015, Washington’s share of the legal adult use market had risen to nearly half.

[recirclink id=323070]
ArcView CEO Troy Dayton added:

Washington has remained on the industry’s frontier as one of the first states to legalize both medical and adult use. They have seen some hiccups in getting their framework off the ground, but strong consumer demand is helping the market flourish.

The state is adopting new rules in July that are designed to bridge the gap between the medical use and recreational use markets. These changes include:

  • Medical dispensaries will need a retail license in order to operate.
  • Cannabis sales to medical patients from retail locations will be subject to a 37% retail excise tax.
  • Patient collective gardens will be allowed under more stringent regulations.

These changes are expected to have a major effect on the medical market.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618